KR100516676B1 - 안면 수술에서의 레보부피바카인의 용도 - Google Patents

안면 수술에서의 레보부피바카인의 용도 Download PDF

Info

Publication number
KR100516676B1
KR100516676B1 KR10-1999-7007975A KR19997007975A KR100516676B1 KR 100516676 B1 KR100516676 B1 KR 100516676B1 KR 19997007975 A KR19997007975 A KR 19997007975A KR 100516676 B1 KR100516676 B1 KR 100516676B1
Authority
KR
South Korea
Prior art keywords
levobupivacaine
surgery
bupivacaine
administered
patients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR10-1999-7007975A
Other languages
English (en)
Korean (ko)
Other versions
KR20000075896A (ko
Inventor
브라이언 알버트 제너리
Original Assignee
다윈 디스커버리 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 다윈 디스커버리 리미티드 filed Critical 다윈 디스커버리 리미티드
Publication of KR20000075896A publication Critical patent/KR20000075896A/ko
Application granted granted Critical
Publication of KR100516676B1 publication Critical patent/KR100516676B1/ko
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
KR10-1999-7007975A 1997-03-03 1998-03-03 안면 수술에서의 레보부피바카인의 용도 Expired - Lifetime KR100516676B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9704352.5A GB9704352D0 (en) 1997-03-03 1997-03-03 Levobupivacaine and its use
GB9704352.5 1997-03-03
PCT/GB1998/000657 WO1998038996A1 (en) 1997-03-03 1998-03-03 The use of levobupivacaine in facial surgery

Publications (2)

Publication Number Publication Date
KR20000075896A KR20000075896A (ko) 2000-12-26
KR100516676B1 true KR100516676B1 (ko) 2005-09-22

Family

ID=10808603

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-1999-7007975A Expired - Lifetime KR100516676B1 (ko) 1997-03-03 1998-03-03 안면 수술에서의 레보부피바카인의 용도

Country Status (20)

Country Link
US (1) US5919804A (cg-RX-API-DMAC7.html)
EP (1) EP0981347B1 (cg-RX-API-DMAC7.html)
JP (1) JP2001513812A (cg-RX-API-DMAC7.html)
KR (1) KR100516676B1 (cg-RX-API-DMAC7.html)
CN (1) CN1089585C (cg-RX-API-DMAC7.html)
AT (1) ATE240730T1 (cg-RX-API-DMAC7.html)
AU (1) AU730390B2 (cg-RX-API-DMAC7.html)
BR (1) BR9808303A (cg-RX-API-DMAC7.html)
CA (1) CA2279497C (cg-RX-API-DMAC7.html)
DE (1) DE69814851T2 (cg-RX-API-DMAC7.html)
DK (1) DK0981347T3 (cg-RX-API-DMAC7.html)
ES (1) ES2199423T3 (cg-RX-API-DMAC7.html)
GB (1) GB9704352D0 (cg-RX-API-DMAC7.html)
HU (1) HU225151B1 (cg-RX-API-DMAC7.html)
IL (1) IL131084A0 (cg-RX-API-DMAC7.html)
NO (1) NO322446B1 (cg-RX-API-DMAC7.html)
PL (1) PL190900B1 (cg-RX-API-DMAC7.html)
PT (1) PT981347E (cg-RX-API-DMAC7.html)
WO (1) WO1998038996A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA981779B (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2294950C (en) * 1997-07-21 2009-04-07 Darwin Discovery Limited Levobupivacaine and its use
ATE239474T1 (de) * 1997-07-22 2003-05-15 Darwin Discovery Ltd Verwendung von levobupivacain
AU752802C (en) 1997-11-14 2006-04-13 Pacira Pharmaceuticals, Inc. Production of multivesicular liposomes
WO2000003660A1 (en) 1998-07-17 2000-01-27 Skyepharma, Inc. Biodegradable compositions for the controlled release of encapsulated substances
WO2002096368A2 (en) * 2001-05-31 2002-12-05 Skyepharma Inc. Encapsulation of nanosuspensions in liposomes and microspheres
ES2397574T3 (es) 2002-07-30 2013-03-08 Omeros Corporation Procedimiento y soluciones de irrigación oftalmológica
DE10260313A1 (de) * 2002-12-20 2004-07-15 Siemens Ag Elektrische Maschine mit Wicklungen aus Litze
US20050176823A1 (en) * 2004-02-10 2005-08-11 Diaz Robert L. Intra-operative procedure for post-operative pain control
AU2013201465B2 (en) 2012-10-24 2016-03-03 Rayner Intraocular Lenses Limited Stable preservative-free mydriatic and anti-inflammatory solutions for injection
TWI705812B (zh) 2014-12-01 2020-10-01 奥默羅斯公司 用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12151024B2 (en) 2021-01-22 2024-11-26 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12285419B2 (en) 2021-10-14 2025-04-29 Pacira Pharmaceuticals, Inc. Bupivacaine multivesicular liposome formulations and uses thereof
US12070454B1 (en) 2022-05-05 2024-08-27 Pfof Llc Anesthetic nerve block and method
CN119677554A (zh) 2022-05-05 2025-03-21 普络夫有限责任公司 麻醉神经阻滞和方法
US12280149B1 (en) 2024-05-20 2025-04-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12251472B1 (en) 2024-05-20 2025-03-18 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12156940B1 (en) 2024-05-20 2024-12-03 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695576A (en) * 1984-07-09 1987-09-22 Astra Lake Medel Aktiebolag L-N-n-propylpipecolic acid-2,6-xylidide
AU694453B2 (en) * 1993-10-13 1998-07-23 Darwin Discovery Limited Analgesic agent and its use
GB9321061D0 (en) * 1993-10-13 1993-12-01 Chiroscience Ltd Analgestic agent and its use
CA2216583C (en) * 1995-04-13 2007-10-30 Chiroscience Limited Levobupivacaine and its use as an anaesthetic in pregnant women

Also Published As

Publication number Publication date
ZA981779B (en) 1999-03-03
NO994257L (no) 1999-11-02
HK1022651A1 (en) 2000-08-18
ES2199423T3 (es) 2004-02-16
PL335561A1 (en) 2000-05-08
DK0981347T3 (da) 2003-09-15
DE69814851D1 (de) 2003-06-26
HUP0000873A3 (en) 2002-10-28
WO1998038996A1 (en) 1998-09-11
KR20000075896A (ko) 2000-12-26
EP0981347A1 (en) 2000-03-01
DE69814851T2 (de) 2004-01-22
AU6630498A (en) 1998-09-22
US5919804A (en) 1999-07-06
HU225151B1 (en) 2006-07-28
PT981347E (pt) 2003-09-30
PL190900B1 (pl) 2006-02-28
NO322446B1 (no) 2006-10-09
ATE240730T1 (de) 2003-06-15
NO994257D0 (no) 1999-09-02
GB9704352D0 (en) 1997-04-23
CN1249684A (zh) 2000-04-05
HUP0000873A2 (hu) 2000-09-28
JP2001513812A (ja) 2001-09-04
IL131084A0 (en) 2001-01-28
BR9808303A (pt) 2000-05-16
EP0981347B1 (en) 2003-05-21
CA2279497A1 (en) 1998-09-11
CA2279497C (en) 2009-01-20
AU730390B2 (en) 2001-03-08
CN1089585C (zh) 2002-08-28

Similar Documents

Publication Publication Date Title
AU730390B2 (en) The use of levobupivacaine in facial surgery
EP0727210B1 (en) Analgesic agent and its use
US5849763A (en) Use of levobupivacaine as an anesthetic agent
CA2294921C (en) Levobupivacaine and its use
KR100535554B1 (ko) 소아과 수술에서의 레보부피바카인의 용도
HK1006420B (en) Analgesic agent and its use
Boezaart et al. A comparison of propofol and remifentanil for sedation and limitation of movement during periretrobulbar block
Yalcin Maxillofacial Surgery
Rewari et al. Remifentanil and propofol sedation for retrobulbar nerve block
HUP0000756A2 (hu) Levobupivakain vagy ropivakain alkalmazása migrén kezelésére alkalmas gyógyszerkészítmények előállítására
HU224226B1 (hu) Levobupivacaine alkalmazása terhesség esetén használható érzéstelenítő hatású gyógyszerkészítmény előállítására
HU214629B (hu) Eljárás műtét utáni hányinger és hányás kezelésére szolgáló gyógyszerkészítmény előállítására
HUP0100599A2 (hu) Lokális anesztetikumok új alkalmazása vaszkuláris fejfájások ellen
WO1998038997A1 (en) Use of levobupivacaine in combination with opiods or alfa2-agonists for providing anaesthesia or analgesia
MXPA99008055A (es) Uso de levobupivacaina en cirugia facial
HK1022651B (en) The use of levobupivacaine in facial surgery
Khalil et al. Alfentanil decreases the excitatory phenomena of sodium methohexital
CA2505487C (en) Levobupivacaine and its use as an anaesthetic in obstetrics
CA2173207C (en) Levobupivacaine and its use as an anaesthetic in patients having or disposed to depressed myocardial contractility
JP2001131073A (ja) 疼痛治療剤
Abdelmonem et al. COMPARISON BETWEEN INTRATHECAL ISOBARIC LEVOBUPIVACAINE VERSUS HYPERBARIC BUPIVACAINE IN ELDERLY PATIENTS UNDERGOING TROCHANTERIC FRACTURE SURGERY

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 19990902

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20030303

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20041214

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20050725

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20050830

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20050829

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20080825

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20090824

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20100825

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20110718

Start annual number: 7

End annual number: 7

FPAY Annual fee payment

Payment date: 20120802

Year of fee payment: 8

PR1001 Payment of annual fee

Payment date: 20120802

Start annual number: 8

End annual number: 8

FPAY Annual fee payment

Payment date: 20130801

Year of fee payment: 9

PR1001 Payment of annual fee

Payment date: 20130801

Start annual number: 9

End annual number: 9

FPAY Annual fee payment

Payment date: 20150729

Year of fee payment: 11

PR1001 Payment of annual fee

Payment date: 20150729

Start annual number: 11

End annual number: 11

FPAY Annual fee payment

Payment date: 20160727

Year of fee payment: 12

PR1001 Payment of annual fee

Payment date: 20160727

Start annual number: 12

End annual number: 12

FPAY Annual fee payment

Payment date: 20170804

Year of fee payment: 13

PR1001 Payment of annual fee

Payment date: 20170804

Start annual number: 13

End annual number: 13

EXPY Expiration of term
PC1801 Expiration of term

Termination date: 20180903

Termination category: Expiration of duration